Legacy

August 25, 2020

DALLAS - Aug. 25, 2020 - Breastfeeding secures delivery of sugar and fat for milk production by changing the insulin sensitivity of organs that supply or demand these nutrients, a new study led by UT Southwestern scientists suggests. The findings, published in this month's print issue of Diabetes, could explain how different tissues cooperate to start and maintain lactation and offer strategies to help improve breastfeeding success for mothers who have insufficient milk production.

Epidemiologic studies suggest that breastfeeding protects women from developing Type 2 diabetes, even decades after their children have been weaned. But how this benefit arises has been unclear, explains Maria A. Ramos-Roman, M.D., an associate professor of internal medicine in the division of endocrinology at UT Southwestern.

One hypothesis is that breastfeeding changes how the body uses insulin, the hormone that allows cells to take in glucose from the bloodstream. (Glucose is a type of sugar that powers cells.) Detailed metabolic studies have shown that although pregnancy reduces the body's sensitivity to insulin, lactation may restore insulin sensitivity to a pre-pregnancy state. But it is unclear how this process happens and how it affects highly insulin-sensitive organs, such as the liver or fat tissue.

To learn more, Ramos-Roman and her colleagues recruited 18 women who had recently given birth. Twelve of these women were either exclusively breastfeeding or giving their babies less than 6 ounces of formula per day. The remaining six were exclusively formula feeding.

At five weeks postpartum, each of these women came to UT Southwestern for a detailed medical exam to make sure they were healthy and could safely participate in other parts of the study. One week later, the volunteers returned for a second visit in which they underwent a hyperinsulinemic-euglycemic clamp, a test that quantifies insulin sensitivity. Although the test measures insulin sensitivity for the body overall, these women also received stable isotopes during the test - tracers that helped measure insulin sensitivity specifically for organs of interest, such as the liver, or fat. At a third visit by eight weeks postpartum, the study participants underwent a type of imaging called magnetic resonance spectroscopy that measured the amount of fat in their livers.

The researchers found that all of the women had low blood insulin concentrations characteristic of the postpartum period, regardless of how they were feeding their new babies. However, even at these low insulin levels, after a 12-hour fast, the lactating mothers produced 2.6-fold more glucose and released 2.3-fold more fatty acids from storage in their fat tissue - a process known as lipolysis - than that of the formula feeders. Both glucose production and lipolysis were suppressed in both groups when the researchers mimicked a "fed state" by delivering insulin through the clamp. But suppression of lipolysis was heightened by higher levels of prolactin - the hormone that stimulates milk production - in the lactating mothers, accompanied by lower levels of fatty acids in the blood and lower amounts of fat in their livers.

These results suggest that breastfeeding appears to increase insulin sensitivity in highly insulin-sensitive organs, Ramos-Roman explains. After a 12-hour fast, the liver and fat tissues of lactating mothers release more sugar and fat into the bloodstream than formula-feeding mothers; however, after food intake or under the conditions of a hyperinsulinemic-euglycemic clamp, lactating mothers respond to small increases in insulin levels by holding on to more stored fat than formula-feeding mothers. Both conditions maximize the nutrients available for making milk in breastfeeding women, providing a steady stream from either stored resources or food intake.

These changes in insulin levels and sensitivity might also provide the legacy benefit observed in epidemiologic studies in women who have breastfed, offering a buffer against insulin resistance even decades later, Ramos-Roman says. (These previous studies showed an association between intensity or duration of breastfeeding and a lower incidence of Type 2 diabetes in the mothers.)

In addition, she adds, better understanding of this process could help researchers find new ways to help encourage it in mothers who would like to breastfeed but are having problems with low milk supply - finding ways to stimulate insulin-sensitive tissues to supply more nutrients into or demand less nutrients from the bloodstream could boost milk production.

"Lactation is millions of years old, but we still have a long way to go before we understand all there is to learn," Ramos-Roman says. "If we know better how it happens in the body, we can help improve the health of women and children."
-end-
Other researchers who contributed to this study include Beverley Adams-Huet of UTSW; Majid M. Syed-Abdul and Elizabeth J. Parks of the University of Missouri School of Medicine; and Brian M. Casey, previously of UTSW and now at the University of Alabama.

This study was supported by funds from the American Diabetes Association (1-14-TS-33) and the National Institutes of Health (R03 DK097463).

About UT Southwestern Medical Center

UT Southwestern, one of the premier academic medical centers in the nation, integrates pioneering biomedical research with exceptional clinical care and education. The institution's faculty has received six Nobel Prizes, and includes 24 members of the National Academy of Sciences, 16 members of the National Academy of Medicine, and 13 Howard Hughes Medical Institute Investigators. The full-time faculty of more than 2,500 is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians provide care in about 80 specialties to more than 105,000 hospitalized patients, nearly 370,000 emergency room cases, and oversee approximately 3 million outpatient visits a year.

UT Southwestern Medical Center

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.